Table 3 Associations between NLRP3 inflammasome genetic variants and symptoms of severe acute respiratory syndrome (SARS) and sickness behavior.

From: In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach

Dependent variables

Symptoms (yes/no)

Genetic variants

B

SE

W (df = 1)

p

OR

CI 95%

SARS

SARS

NLPR3 rs10157379 CT

0.477

0.189

6.38

0.012

1.61

1.11–2.33

SARS

NLPR3 rs10157379 CT

0.469

0.190

6.13

0.013

1.60

1.10–2.32

NLPR3 rs10754558 GG

0.523

0.246

4.50

0.034

0.60

0.37–0.96

Cough

NLPR3 rs10157379 CC

−0.684

0.236

8.40

0.004

0.50

0.32–0.80

Runny nose

NLPR3 rs10157379 CC

−0.515

0.229

5.05

0.025

0.60

0.38–0.94

Neurological

Neurological

NLPR3 rs10157379 CC

−2.043

1.022

3.99

0.046

0.13

0.02–0.96

Sickness symptom complex

Fatigue

NLPR3 rs10754558 CG

−0.601

0.182

10.86

0.001

0.55

0.38–0.78

Myalgia

NLPR3 rs10754558 CG

−0.376

0.189

3.95

0.047

0.69

0.47–0.99

Loss of appetite

NLPR3 rs10754558 GG

−0.8372

0.290

8.35

0.004

0.43

0.25–0.76

Headache

NLPR3 rs10754558 CG

−0.401

0.198

4.12

0.042

0.67

0.45–0.99

  1. OR odd’s ratio, CI95% 95% confidence intervals.